Cancer Screening in People Who Have Chronic Disease: The Example of Kidney Disease

Seminars in Dialysis

Volumn 24, Issue 1, 2011, Pages 72-78

  Wong, Germaine ^a,b   Howard, Kirsten ^b   Tong, Allison ^a,b   Craig, Jonathan C ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; EARLY DIAGNOSIS; HEALTH; HUMAN; INCIDENCE; METHODOLOGY; NEOPLASM;

EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; NEOPLASMS; WORLD HEALTH;

EID: 79951803384     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2010.00804.x     Document Type: Article

References (49)

1. Yach D, Hawkes C, Gould CL, Hofman KJ: The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 291:2616-2622, 2004
2. Walter LC, Covinsky KE: Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285:2750-2756, 2001
3. Kronborg O, Jorgensen OD, Fenger C, Rasmussen M: Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 39:846-851, 2004
4. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F for the Minnesota Colon Cancer Control Study: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328:1365-1371, 1993
5. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C: A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 317:559-565, 1998
6. Barratt A, Irwig L, Glasziou P, Cumming RG, Raffle A, Hicks N, Muir Gray JA, Guyatt GH, for the Evidence-Based Medicine Working Group: Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA 281:2029-2034, 1999
7. Andermann A, Blancquaert I, Beauchamp S, Dery V: Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40years. Bull World Health Organ 86:317-319, 2008
8. Wilson JMG, Jungner F: Principles and practice of screening for disease. Geneva: World Health Organization: Public Health Papers 34, 1968.
9. Australian Government of Health and Aging. Australia's Bowel Cancer Screening Pilot and Beyond. FINAL EVALUATION REPORT. 2005. Ref Type: Report
10. Holley JL: Preventive medical screening is not appropriate for many chronic dialysis patients. Semin Dial 13:369-371, 2000
11. Kajbaf S, Nichol G, Zimmerman D: Cancer screening and life expectancy of Canadian patients with kidney failure. Nephrol Dial Transplant 17:1786-1789, 2002
12. LeBrun CJ, Diehl LF, Abbott KC, Welch PG, Yuan CM: Life expectancy benefits of cancer screening in the end-stage renal disease population. Am J Kidney Dis 35:237-243, 2000
13. Kiberd BA, Keough-Ryan T, Clase CM: Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant 3:619-625, 2003
14. EBPG Expert Group on Renal Transplantation: European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment. Nephrol Dial Transplant 17(Suppl 4):36-39, 2002
15. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD Jr, Singer GG, for the American Society of Transplantation: Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 11(Suppl 86):S1-S86, 2000
16. Irwig L, McCaffery K, Salkeld G, Bossuyt P: Informed choice for screening: implications for evaluation. [Review] [23 refs]. BMJ 332:1148-1150, 2006
17. Vajdic CM, McDonald SP, McCredie MRE, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE: Cancer incidence before and after kidney transplantation. JAMA 296:2823-2831, 2006
18. Miao Y, Everly JJ, Gross TG, Tevar AD, First MR, Alloway RR, Woodle ES: De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation 87:1347-1359, 2009
19. Wong G, Webster AC, Chapman JR, Craig JC: Reported cancer screening practices of nephrologists: results from a national survey. Nephrol Dial Transplant 24:2136-2143, 2009
20. Larsson LG, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabár L, Nyström L: Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization. J Natl Cancer Inst Monogr (22):57-61, 1997
21. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE: Breast cancer screening with mammography: overview of Swedish randomised trials.[Erratum appears in Lancet 1993 Nov 27;342(8883):1372]. Lancet 341:973-978, 1993
22. Brown ML, Fintor L: Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat 25:113-118, 1993
23. de Koning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JCJM, Collette HJA, Hendriks JHCL, van der Maas PJ: Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 49:531-537, 1991
24. Duffy SW, Day NE, Tabar L, Chen HH, Smith TC: Markov models of breast tumor progression: some age-specific results. J Natl Cancer Inst (22):93-97, 1997
25. Wong G, Howard K, Chapman JR, Craig JC: Cost-effectiveness of breast cancer screening in women on dialysis. Am J Kidney Dis 52:916-929, 2008
26. Wong G, Howard K, Craig JC, Chapman JR: Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation 85(4):532-541, 2008
27. Egorov V, Kearney T, Pollak SB, Rohatgi C, Sarvazyan N, Airapetian S, Browning S, Sarvazyan A: Differentiation of benign and malignant breast lesions by mechanical imaging. Breast Cancer Res Treat 118:67-80, 2009
28. Abraham L, Geller BM, Yankaskas BC, Bowles EJA, Karliner LS, Taplin SH, Miglioretti DL: Accuracy of self-reported breast cancer among women undergoing mammography. Breast Cancer Res Treat 118:583-592, 2009
29. Murphy AM: Mammography screening for breast cancer: a view from 2 worlds. JAMA 303:166-167, 2010
30. Launoy GD, Bertrand HJ, Berchi C, Talbourdet VY, Guizard AVN, Bouvier VM, Caces ER: Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 115:493-496, 2005
31. Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, Niv Y: Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 100:2519-2525, 2005
32. Walter SD, Frommer DJ, Cook RJ: The estimation of sensitivity and specificity in colorectal cancer screening methods. Cancer Detect Prev 15:465-469, 1991
33. Mulherin SA, Miller WC: Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation Ann Intern Med 137:598-602, 2002
34. Alkhunaizi AM, Ismail A, Yousif BM: Breast fibroadenomas in renal transplant recipients. Transpl Proc 36:1839-1840, 2004
35. Baildam AD, Higgins RM, Hurley E, Furlong A, Walls J, Venning MC, Ackrill P, Mansel RE: Cyclosporin A and multiple fibroadenomas of the breast. Br J Surg 83:1755-1757, 1996
36. Balal M, Seyrek N, Karayaylali I, Paydas S: Report of a renal transplanted patient with fibroadenoma occurring in a short time. Transpl Proc 35:1408-1409, 2003
37. Binokay F, Balal M, Demir E, Paydas S, Soyupak S, Sertdemir Y, Akgul E: Risk of developing fibroadenoma with the use of cyclosporine A in renal transplant recipients. Ren Fail 27:721-725, 2005
38. Kim DM, Kim HL, Chung CH, Park CY: Successful treatment of small-cell lung cancer with irinotecan in a hemodialysis patient with end-stage renal disease. Korean J Intern Med 24:73-75, 2009
39. Kondo Y, Yoshida H, Tomizawa Y, Tateishi R, Shiina S, Tagawa K, Omata M: Percutaneous radiofrequency ablation of hepatocellular carcinoma in 14 patients undergoing regular hemodialysis for end-stage renal disease. AJR, 193:964-969, 2009
40. Obuchi T, Hamanaka W, Yoshida Y, Yanagisawa J, Hamatake D, Shiraishi T, Iwasaki A: Clinical outcome after pulmonary resection for lung cancer patients on hemodialysis. Ann Thorac Surg 88:1745-1748, 2009
41. Carter R, Glasziou P, van Oortmarssen G, de Koning H, Stevenson C, Salkeld G, Boer R: Cost-effectiveness of mammographic screening in Australia. Aust J Public Health 17:42-50, 1993
42. Leshno M, Halpern Z, Arber N: Cost-effectiveness of colorectal cancer screening in the average risk population. Health Care Manag Sci 6:165-174, 2003
43. Whynes DK: Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial. Crit Rev Oncol Hematol 32:155-165, 1999
44. Gyrd-Hansen D, Holund B, Andersen P: A cost-effectiveness analysis of cervical cancer screening: health policy implications. Health Policy 34:35-51, 1995
45. Wong G, Howard K, Chapman JR, Craig JC: Cost-effectiveness of breast cancer screening in women on dialysis. Am J Kidney Dis 52(5):830-833, 2008
46. Brody DS, Miller SM, Lerman CE, Smith DG, Caputo GC: Patient perception of involvement in medical care: relationship to illness attitudes and outcomes. J Gen Intern Med 4:506-511, 1989
47. Marshall DA, Johnson FR, Kulin NA, Özdemir S, Walsh JME, Marshall JK, Van Bebber S, Phillips KA: How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey Health Econ 18:1420-1439, 2009
48. Powell AA, Burgess DJ, Vernon SW, Griffin JM, Grill JP, Noorbaloochi S, Partin MR: Colorectal cancer screening mode preferences among US veterans. Prev Med 49:442-448, 2009
49. Pignone M: Patient preferences for colon cancer screening: the role of out-of-pocket costs. Am J Manag Care 13:390-391, 2007